Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s share price passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.22 and traded as low as $0.17. Arch Therapeutics shares last traded at $0.17, with a volume of 136 shares.
Arch Therapeutics Stock Up 0.1 %
The business’s fifty day simple moving average is $0.22 and its two-hundred day simple moving average is $0.47.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Featured Articles
- Five stocks we like better than Arch Therapeutics
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- How to Capture the Benefits of Dividend Increases
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.